Literature DB >> 12930410

The ageing male and erectile dysfunction.

F Montorsi1, A Briganti, A Salonia, F Deho', G Zanni, A Cestari, G Guazzoni, P Rigatti, C Stief.   

Abstract

Erectile dysfunction is common in the ageing man and reliable therapies are needed. The pathophysiology of erectile dysfunction in this group mainly includes chronic ischaemia, which triggers the deterioration of cavernosal smooth muscle and the development of corporeal fibrosis. Assessing the ageing man with erectile dysfunction who seeks medical treatment should comprise a thorough medical and sexual history, a systemic and focused physical examination and selected blood tests. Oral drug therapy represents a safe and effective option for most ageing men.

Entities:  

Mesh：

Year:  2003        PMID： 12930410     DOI： 10.1046/j.1464-410x.2003.04378.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


  4 in total

1.  Erectile tissue molecular alterations with aging: differential activation of the p42/44 MAP Kinase pathway.

Authors:  Angela Castela; Raquel Soares; Fátima Rocha; Pedro Vendeira; Ronald Virag; Carla Costa
Journal:  Age (Dordr)       Date:  2010-07-14

Review 2.  Gene therapy as future treatment of erectile dysfunction.

Authors:  Naoki Yoshimura; Ryuichi Kato; Michael B Chancellor; Joel B Nelson; Joseph C Glorioso
Journal:  Expert Opin Biol Ther       Date:  2010-09       Impact factor: 4.388

3.  Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension.

Authors:  Rafael Paternostro; Birgit B Heinisch; Thomas Reiberger; Mattias Mandorfer; Remy Schwarzer; Berit Seeland; Michael Trauner; Markus Peck-Radosavljevic; Arnulf Ferlitsch
Journal:  Liver Int       Date:  2018-02-20       Impact factor: 5.828

4.  Testosterone deficiency causes penile fibrosis and organic erectile dysfunction in aging men. Evaluating association among Age, TDS and ED.

Authors:  Fabrizio Iacono; Domenico Prezioso; Antonio Ruffo; Ester Illiano; Leo Romis; G Di Lauro; Giuseppe Romeo; Bruno Amato
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.